About Magellan Life Sciences
Magellan Life Sciences is a Healthcare company based in Hyderabad (India) founded in 2013. Its focus areas include Life Sciences, Immunotherapy, Vaccine and Therapeutic. Its legal entity in India is Magellan Life Sciences Private Limited (U73100TG2013PTC090647).
Company details
Develops natural non-caloric sweetener along with proprietary vaccines, biologics, and food biotech products. In the vaccines division, the company is developing subunit vaccine antigens for tropical diseases such as malaria, chikungunya, dengue, Ebola, and MERS. In the biologicals division, it is developing protein therapeutics for Diabetes, Cancer, Arthritis, etc. In the food biotech division, it is developing protein-based food supplements called Magellan PALATES, which include non-sugar sweeteners Brazzein isolated from exotic fruit Oubli, antimicrobial and coagulating agents, etc. Also, it has a service division named BacMam (Baculovirus mediated gene transfer into Mammalian cells) for protein expression and purification, along with protein analysis and characterization services, and it claims to be the only company in Asia offering BacMam protein expression platform service.
- Headquarters Hyderabad, India
- SectorsHealthcare
- Email••••••••
- Website magellanlifesciences.com
- Social X
- Legal Name Magellan Life Sciences Private Limited
- Date of Incorporation 22 Oct, 2013
- Jurisdiction Hyderabad, Telangana, India
- Net Loss-₹33,562
FY 2022 · 0% margin
- EBITDA-₹8,562
FY 2022 · 0% margin
- InvestorsRoquette
& 1 more
Associated legal entities of Magellan Life Sciences
Magellan Life Sciences is associated with 2 registered companies on The Company Check; the primary company is Magellan Life Sciences Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Magellan Life Sciences Private Limited CIN U73100TG2013PTC090647 | Active | 22 Oct 2013 | Hyderabad, Telangana | 3 | View details | ||
| Magellan Synthetic Biology Llp CIN AAU-5704 | Active | 05 Nov 2020 | Satuli, Maharashtra | 2 | View details |
Funding Insights of Magellan Life Sciences
- Total Rounds 2
- Investors Count 2
All 2 funding rounds of Magellan Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Magellan Life Sciences
Magellan Life Sciences has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Roquette and SOSV.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital and accelerator services are provided across multiple sectors. | sosv.com | Cork, Ireland | ||
Plant-based pharma, nutraceuticals, and cosmetics are manufactured as a CDMO. | 1933 | roquette.com | Lestrem, France |
Investor details for Magellan Life Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Magellan Life Sciences Private Limited (Magellan Life Sciences)
Magellan Life Sciences Private Limited is the primary company behind Magellan Life Sciences. The boards of the 2 registered companies of Magellan Life Sciences currently have 4 directors; the longest-serving is Abhiram Dukkipati, appointed in 2013. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Abhiram Dukkipati DIN 03598294 | Director | 22 Oct 2013 | 13 yrs | Magellan Life Sciences Private Limited |
| Nageswararao Dukkipati DIN 02009886 | Director | 22 Oct 2013 | 13 yrs | Magellan Life Sciences Private Limited |
| Laxmi Shankar Wagle DIN 02347697 | Designated Partner | 05 Nov 2020 | 5 yrs 11 mo | Magellan Synthetic Biology Llp, Magellan Life Sciences Private Limited |
| Edouard Jean Marc Nuttin DIN 09165623 | Designated Partner | 05 May 2021 | 5 yrs 5 mo | Magellan Synthetic Biology Llp |
Financials of Magellan Life Sciences
Figures of Magellan Life Sciences Private Limited, the primary company behind Magellan Life Sciences, for FY 2022. Net loss was -₹33,562 (0% margin). EBITDA was -₹8,562 (0% margin). Revenue has grown at a compounded annual rate of -100% over three years and -100% over five years.
- -₹33,562Net loss · 0% margin
- -₹8,562EBITDA · 0% margin
- ₹1 LakhPaid-up capital
- -100%Revenue CAGR, 3 years
- -100%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Magellan Life Sciences Private Limited are on its company page.
Detailed financial statements for Magellan Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Magellan Life Sciences
3 dated milestones of Magellan Life Sciences across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Magellan Life Sciences is founded.
- Funding First funding round.
- Funding Latest funding round, Seed,.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Magellan Life Sciences
Complete news archive for Magellan Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Magellan Life Sciences
Magellan Life Sciences was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Magellan Life Sciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Develops natural non-caloric sweetener along with proprietary vaccines, biologics, and food biotech products. In the vaccines division, the company is developing subunit vaccine antigens for tropical diseases such as malaria, chikungunya, dengue, Ebola, and MERS. In the biologicals division, it is developing protein therapeutics for Diabetes, Cancer, Arthritis, etc. In the food biotech division, it is developing protein-based food supplements called Magellan PALATES, which include non-sugar sweeteners Brazzein isolated from exotic fruit Oubli, antimicrobial and coagulating agents, etc. Also, it has a service division named BacMam (Baculovirus mediated gene transfer into Mammalian cells) for protein expression and purification, along with protein analysis and characterization services, and it claims to be the only company in Asia offering BacMam protein expression platform service.
Magellan Life Sciences is associated with 2 legal entities: Magellan Life Sciences Private Limited, Magellan Synthetic Biology Llp.
The legal entities of Magellan Life Sciences currently have 4 directors, including Laxmi Shankar Wagle, Edouard Jean Marc Nuttin, Abhiram Dukkipati and others.